Logo
Login

Anthera Pharmaceuticals Inc SEC Filings

Filed On Filing
12 Sep 2018 Form 3: McManigle Mark Drew, Director

No securities owned
30 Jul 2018 15-12B
26 Jul 2018 EFFECT
26 Jul 2018 EFFECT
26 Jul 2018 EFFECT
26 Jul 2018 EFFECT
26 Jul 2018 EFFECT
26 Jul 2018 EFFECT
26 Jul 2018 EFFECT
20 Jul 2018 S-8 POS
20 Jul 2018 S-8 POS
20 Jul 2018 RW
20 Jul 2018 S-8 POS
20 Jul 2018 S-8 POS
20 Jul 2018 S-8 POS
20 Jul 2018 S-8 POS
20 Jul 2018 S-8 POS
20 Jul 2018 S-8 POS
20 Jul 2018 POS AM
20 Jul 2018 POS AM

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans